Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF34P is annotated as a pseudogene corresponding to a member of the Rho guanine nucleotide exchange factor family in Homo sapiens[2][4][6]. Pseudogenes like ARHGEF34P do not code for functional proteins and therefore are not direct molecular targets for drugs, nor do they participate in canonical signaling pathways or therapeutic targeting. The gene may be listed in gene databases and genomics resources, often in association with the family of Rho guanine nucleotide exchange factors, but no evidence indicates that it functions as an enzyme, receptor, or has druggability[2][4][6][8]. No known biological functions, disease associations, or pharmacological interactions are documented for ARHGEF34P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho guanine nucleotide exchange factor 34, pseudogene (ARHGEF34P).